相关实验视频

Updated: Jan 10, 2026

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke

Published on: November 29, 2024

ACE2:在COVID-19后的神经退行症中是朋友还是敌人?

Svetlana V Kononova¹, Natalia V Bobkova¹, Rimma A Poltavtseva^1,2

¹Institute of Cell Biophysics, Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences", Pushchino 142290, Russia.

International journal of molecular sciences

|November 27, 2025

概括

ангиотензин转化酶2 (ACE2) 对大脑健康和神经递质系统至关重要. 这篇评论探讨了SARS-CoV-2尖端蛋白是否存在.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
病毒学病毒学

背景情况:

ангиотензин转化酶2 (ACE2) 是renin-angiotensin系统中的一个关键调节剂.
ACE2具有多种功能,包括氨基酸运输,细胞粘附和信号通路的参与.
ACE2 影响大脑中的神经递质系统.

研究的目的:

调查SARS-CoV-2尖端蛋白暂时ACE2失活在阿尔茨海默氏症类神经退行症中的作用.
确定ACE2是否可以作为与SARS-CoV-2相关的神经退行性疾病的生物标志物或治疗标.

主要方法:

文献综述和对ACE2功能和SARS-CoV-2相互作用现有研究的分析.
检查调查病毒尖端蛋白对神经通路的影响的研究.
关于ACE2表达及其与神经退行症相关性的数据综合.

主要成果:

ACE2是SARS-CoV-2的主要受体.
大脑中的低ACE2水平,再加上SARS-CoV-2感染,会增加神经退行性疾病的风险.
SARS-CoV-2 尖端蛋白与 ACE2 的相互作用可能导致类似阿尔茨海默氏症的病理.

结论:

由SARS-CoV-2尖端蛋白暂时禁用ACE2是类似阿尔茨海默氏症的神经退行症的潜在因素.
ACE2是针对SARS-CoV-2引起的神经损伤的治疗干预的有希望的目标.
需要进一步的研究,以充分阐明ACE2作为神经退行症中的生物标志物和治疗点的作用.

关键词:

在ACE2中,ACE2是ACE2.阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在 COVID-19 疫情中,多功能蛋白质多功能蛋白质神经传递器系统的神经传递器系统宁血管氨酸系统

更多相关视频

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

相关概念视频

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...